Stay ahead of diabetes without fingersticks*

Spend more time doing what you enjoy with a smart continuous glucose monitor (CGM) that helps you stay ahead of highs and lows, 24/7.

Learn more

* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings. Refer to system user guide.

Guardian 4
smart CGM system

Guardian 4
smart CGM

Stay ahead with smarter technology

Real-time glucose readings
See how you're trending on your mobile device with sensor glucose readings every 5 minutes.
Advanced predictive glucose insights
Know up to 1-hour in advance of a high or low 24/7. ^1,†
Advanced notifications, alerts, and alarms
Set and customise your glucose notifications, alerts, and alarm volumes to meet your preferences.
Activity Diary
Record insulin, exercise, meals, and more in the integrated logbook to understand how activities may affect your glucose trends.

Woman looking at smartphone

Abdominal site is approved for ages >17. Actor portrayal.

Stay connected with shareable data

Share glucose data with your friends and family.
With remote monitoring, you can keep those who are important to you informed about your data. Share changes in your glucose values by having real-time text alerts sent securely to their mobile phone.

Share personalised glucose reports.
Discover new ways to improve your therapy by collaborating with your healthcare provider with personalised glucose management reports from CareLink™ Personal software.

Stay on track for improved health²

Get real results with the Guardian 4 system²

Predictive alerts can help reduce hypoglycemia and help maintain time in range.^3,4
Predictive glucose alerts can help reduce hypoglycaemia (low) events by 59% and hyperglycaemia (high) events by 39%.⁵

Smart MDI System

The Medtronic Smart MDI system includes InPen™ and Guardian™ 4 Sensor, with features that allow you to stay ahead of your glucose levels.

Real time CGM with predictive glucose alerts
Records glucose levels every 5 minutes, 24/7 with no fingersticks*
Alerts of lows and highs up to 60 minutes ahead of time with no fingersticks*
Personalised insulin dosing
Insulin tracking
Dose calculator
Dose reminder

Learn more CGM and InPen apps features

Features		InPen^TM app	Guardian^TM app
Setup CGM Transmitter Bluetooth^® pairing
Setup	CGM Transmitter Bluetooth^® pairing
Insulin pen Bluetooth^® pairing
	Insulin pen Bluetooth^® pairing
Tracking Current & historical sensor glucose
Tracking	Current & historical sensor glucose
Glucose change - direction & rate arrows
	Glucose change - direction & rate arrows
Current & historical insulin doses from InPen System
	Current & historical insulin doses from InPen System
Active insulin.
	Active insulin
Notifications & Alerts Low & high glucose alerts (current / predicted)
Notifications & Alerts	Low & high glucose alerts (current / predicted)
Glucose rise / fall alerts
	Glucose rise / fall alerts
Optional blood glucose calibrations
	Optional blood glucose calibrations
Transmitter battery / communication
	Transmitter battery / communication
Sensor end of life
	Sensor end of life
Insulin cartridge & inPen system replacement reminder
	Insulin cartridge & inPen system replacement reminder
Dose reminder (rapid-acting & long-acting)
	Dose reminder (rapid-acting & long-acting)
Insulin temperature
	Insulin temperature
Logging Carb / meal logging (does not transfer between apps)
Logging	Carb / meal logging (does not transfer between apps)
Manual insulin logging (does not transfer between apps)
	Manual insulin logging (does not transfer between apps)
Active logging
	Active logging
Dosing Dose calculator & recommendations
Dosing	Dose calculator & recommendations
Shareable reports Care partner SNS (via CareLink™ Connect)
Shareable reports	Care partner SNS (via CareLink™ Connect)
Carelink glucose reports
	Carelink glucose reports
Insights reports - glucose & doses
	Insights reports - glucose & doses

Enter your information and we'll contact you with more information about the Guardian 4 smart CGM system.

Request a call today, to discuss the benefits of Guardian™ Connect with a Medtronic Diabetes Therapy Consultant.

This form takes less than ~60 seconds to complete.

* indicates fields that are required

Are you an existing customer?*

Yes No

Who is living with diabetes?*

Type of diabetes?*

How is your diabetes currently managed?*

Which product(s) and/or service(s) are you interested in?

MiniMed™ 780G Insulin Pump System

Continuous Glucose Monitoring (CGM)

i-Port Advance™ injection port

InPen™ Smart Insulin Pen

First name*

Last name*

Phone*

Postcode*

Email*

By ticking this box and providing information, I understand and agree that my personal information is being collected by Medtronic and entered into a database for the purpose of communicating offers and specials related to Medtronic products, services and technological advancements. **Be sure to discuss questions specific to your health and treatments with a healthcare professional.

References

® The Bluetooth(R) wordmark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.

* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

§ vs. using BG monitoring, or a CGM system with no predictive alert capability

† Proper mobile device, settings and human interaction required.

User interaction required. Diabetes treatment decisions should be made based on a combination of SG readings, trend arrows, glucose target ranges, active alerts, and recent events (such as insulin doses, exercise, meals, and medications)
Miller, K., Kanapka, L., Bauza, C., Laffel, L. 898-P: Benefit of Continuous Glucose Monitoring (CGM) in Reducing Hemoglobin A1c Is Sustained through 12 Months of Use among Adolescents and Young Adults with Type 1 Diabetes (T1D). Diabetes. 2020;69(Supplement 1). doi:10.2337/db20-898-p
Haskova A, et al. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial. Diabetes Care 2020;43:2744-2750
Battelino T, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range Diabetes Care 2019;42:1593-1603
Abraham SB, et al. Improved Real-World Glycemic Control with Continuous Glucose Monitoring System Predictive Alerts. Journal of Diabetes Science and Technology 2021; 15(1):91-97

ALWAYS FOLLOW THE DIRECTIONS FOR USE
A healthcare professional should assist in programming of the device prior to use, based on various patient-specific criteria and targets. For additional product and safety information, please consult the Instructions for Use.
InPen™ is intended for single-patient use by people with diabetes for the self-injection of a desired dose of insulin.

The Guardian 4 sensor is intended for use with the Guardian 4 transmitter to monitor glucose levels in persons with diabetes where self-monitoring of blood glucose (SMBG) is indicated. The sensor is designed to replace fingerstick blood glucose (BG)readings for diabetes treatment decisions. The sensor is intended for insertion into persons ages 7 years and older. The sensor is intended for insertion into the back of the upper arm or the upper buttocks in persons ages 7 through 17 years. The sensor is intended for insertion into the back of the upper arm or the abdomen in persons ages 18 years and older.

©2023 Medtronic. All rights reserved. Medtronic, Medtronic logo, and Further, Together are trademarks of Medtronic. SpringCM Approval# 13245-092023. Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company. Android is a trademark of Google LLC